AltC Acquisition, ProShares UltraPro Short QQQ, Spring Valley Acquisition, BigBear.ai, and Aptevo Therapeutics are the five Small Cap stocks to watch today, according to MarketBeat's stock screener tool. Small-cap stocks are shares of companies whose total market capitalization generally falls between about $300 million and $2 billion. Because these firms are smaller and less established than mid- or large-caps, their shares often carry higher growth potential alongside greater volatility and risk. Investors may include small caps in a diversified portfolio seeking above-average returns. These companies had the highest dollar trading volume of any Small Cap stocks within the last several days.
AltC Acquisition (ALCC)
AltC Acquisition Corp. does not have significant operations. It intends to effect a merger, capital stock exchange, asset acquisition, stock purchase, reorganization, or other business combination with one or more businesses. The company was formerly known as Churchill Capital Corp VIII and changed its name to AltC Acquisition Corp.
ALCC stock traded down $2.68 during mid-day trading on Wednesday, reaching $62.77. 24,789,620 shares of the stock traded hands, compared to its average volume of 723,393. The business has a 50-day moving average of $36.64 and a two-hundred day moving average of $31.99. AltC Acquisition has a 52 week low of $10.27 and a 52 week high of $18.80.
Read Our Latest Research Report on ALCC
ProShares UltraPro Short QQQ (SQQQ)
ProShares UltraPro Short QQQ (the Fund) seeks daily investment results, which corresponds to three times the inverse of the daily performance of the NASDAQ-100 Index (the Index). The Index includes 100 of the non-financial domestic and international issues listed on National Association of Securities Dealers Automated Quotation (NASDAQ) Stock Market.
NASDAQ:SQQQ traded up $0.01 during mid-day trading on Wednesday, hitting $22.48. 67,822,557 shares of the company's stock traded hands, compared to its average volume of 61,690,080. The firm has a 50 day moving average of $28.07 and a two-hundred day moving average of $30.76. ProShares UltraPro Short QQQ has a 12 month low of $21.52 and a 12 month high of $57.95.
Read Our Latest Research Report on SQQQ
Spring Valley Acquisition (SV)
Shares of Spring Valley Acquisition stock traded up $3.67 during midday trading on Wednesday, hitting $42.49. The company had a trading volume of 17,909,877 shares, compared to its average volume of 530,580. Spring Valley Acquisition has a 1-year low of $8.56 and a 1-year high of $11.23. The business's 50 day simple moving average is $23.55 and its two-hundred day simple moving average is $21.42.
Read Our Latest Research Report on SV
BigBear.ai (BBAI)
BigBear.ai Holdings, Inc. provides artificial intelligence-powered decision intelligence solutions. It offers national security, supply chain management, and digital identity and biometrics solutions. The company also provides data ingestion, data enrichment, data processing, artificial intelligence, machine learning, predictive analytics, and predictive visualization solutions and services.
Shares of NYSE BBAI traded down $0.09 during mid-day trading on Wednesday, hitting $3.97. The company had a trading volume of 177,977,685 shares, compared to its average volume of 38,845,663. BigBear.ai has a 12 month low of $1.17 and a 12 month high of $10.36. The firm has a market cap of $1.15 billion, a P/E ratio of -5.04 and a beta of 3.29. The business's 50-day simple moving average is $3.44 and its 200-day simple moving average is $3.99. The company has a debt-to-equity ratio of 0.55, a current ratio of 1.66 and a quick ratio of 1.66.
Read Our Latest Research Report on BBAI
Aptevo Therapeutics (APVO)
Aptevo Therapeutics Inc., a clinical-stage research and development biotechnology company, focuses on developing immunotherapeutic candidates for the treatment of various forms of cancer in the United States. It develops its products using ADAPTIR and ADAPTIR-FLEX platforms to generate monospecific, bispecific, and multi-specific antibody candidates capable of enhancing the human immune system against cancer cells.
Aptevo Therapeutics stock traded up $2.57 during trading hours on Wednesday, hitting $5.39. The stock had a trading volume of 119,354,561 shares, compared to its average volume of 557,684. The company has a 50-day moving average of $9.14 and a two-hundred day moving average of $143.05. Aptevo Therapeutics has a fifty-two week low of $2.81 and a fifty-two week high of $485.37.
Read Our Latest Research Report on APVO
Further Reading
This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider AltC Acquisition, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and AltC Acquisition wasn't on the list.
While AltC Acquisition currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
With the proliferation of data centers and electric vehicles, the electric grid will only get more strained. Download this report to learn how energy stocks can play a role in your portfolio as the global demand for energy continues to grow.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
